<DOC>
	<DOC>NCT01122667</DOC>
	<brief_summary>This study will evaluate the Area Under the Curve (AUC(0 to infinity)) of anacetrapib in subjects with impaired renal function and healthy matched control subjects.</brief_summary>
	<brief_title>Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Anacetrapib</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<criteria>Female subjects of reproductive potential test negative for pregnancy and agree to use two acceptable methods of birth control throughout the study Subject is in good health If Subject is a smoker, smoking is limited to no more than 10 cigarettes per day Subject has a history of stroke, chronic seizures or major neurological disorder Subject has a history of cancer Subject is unable to refrain from or anticipates the use of any prescription or nonprescription medication during the study Subject consumes excessive amounts of alcohol or caffeine Subject has had major surgery, donated blood or participated in another investigational study within the past 4 weeks Subject is a nursing mother Subject has had a kidney removed or has a functioning renal transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Renal Insufficiency</keyword>
</DOC>